Humacyte said it will use the money to support sales of its recently FDA-approved product Symvess and prepare an application ...
A number of stocks fell in the afternoon session after the CPI print of 4.2% annual inflation (the hottest since 2023) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results